NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）

Updated: 2026-02-04

Source: DeepSeek model data

AI Brand Performance Analysis

As of 2026-02-04, NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）'s data on the DeepSeek platform in the 抗肿瘤 DNA 疫苗新药研发 category shows: The overall mention rate is 0.00%, below the industry average by 14.3 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.

Brand OverviewPeriod: 2026-01-29 to 2026-02-04

Mention Rate：

NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）'s Mention Rate is 0.00%, lower than 0.6% of competitors

First Mention：

NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）'s First Mention is 0.00%, lower than 0.9% of competitors

Preferred Rate：

NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）'s Preferred Rate is 0.00%, lower than 100.0% of competitors

Positive Rate：

NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）'s Positive Rate is 0.00%, lower than 8.9% of competitors

Negative Rate：

NMM 肿瘤治疗性 DNA 疫苗（ZD - 001）'s Negative Rate is 0.00%, higher than 96.3% of competitors

Brand Cognition

Data TrendsPeriod: 2026-01-29 to 2026-02-04

Brand ReputationPeriod: 2026-01-29 to 2026-02-04

Positive Keywords Cloud

Negative Keywords Cloud

Competitor ComparisonPeriod: 2026-01-29 to 2026-02-04

Competitor	Mention Rate	First Mention	Preferred Rate	Positive Rate	Negative Rate	Actions
NNMM 肿瘤治疗性 DNA 疫苗（ZD - 001） (Current Brand)	0%	0%	0%	0%	0%	View Details